| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |